Branded PPI denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for branded ppi are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for Branded PPIs

Aetna requires prior authorization (PA) for branded proton pump inhibitors because its clinical policy classifies generic PPIs as preferred first-line therapy. The PA process is Aetna's mechanism for verifying that a member has a documented clinical reason to use the non-preferred branded product. A PA denial — whether for failure to obtain authorization in advance or for failure to meet the authorization criteria — is fully appealable.

## Federal Appeal Rights

Under ACA §2719, all pre-service authorization denials on non-grandfathered plans are subject to internal appeal and then independent external review. ERISA plans carry equivalent rights under ERISA §503. You have approximately four months from the final internal denial to request external review. If the clinical situation is urgent, request expedited review, which requires a decision within 72 hours.

## Appeal Process and Timeline

1. Request the denial letter — it must specify which PA criteria were not met. 2. Gather missing documentation and submit an internal appeal; for pre-service appeals, Aetna must decide within 30 days (15 days in some plan types). 3. If denied again, escalate immediately to external review within the four-month window. 4. For urgent situations, submit the expedited review request simultaneously with your internal appeal — you do not have to wait for the internal decision.

## Documentation to Gather

• Medical-necessity letter from the prescriber: must address each PA criterion listed in Aetna's policy, including documented diagnosis, clinical severity, and prior-therapy history.
• Prior generic PPI trial records: dates initiated, duration of therapy, documented clinical response (e.g., symptom scoring, endoscopic follow-up), and reason for discontinuation.
• Diagnosis-supporting records: endoscopy with biopsy reports, pH monitoring, imaging, or specialist consultation notes that establish severity and chronicity.
• Adverse event or intolerance documentation: chart notes, pharmacy records, or allergy-flagging records if generic alternatives were not tolerated.
• Prescriber attestation: a signed statement confirming that the branded product is medically necessary and that generic alternatives are inadequate.

## Criteria-Mapping Strategy

Download Aetna's current Pharmacy Clinical Policy Bulletin for the specific branded PPI. List every stated PA criterion. For each criterion, identify the exact document and page in your clinical record that satisfies it. Present this as an indexed exhibit list with the appeal letter. Aetna's medical reviewers are required to adjudicate based on the published criteria — a thorough point-by-point response eliminates room for continued denial on the same grounds.